NCS Multistage Holdings (NCSM) EBITDA (2016 - 2026)

NCS Multistage Holdings' EBITDA history runs 11 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• On a quarterly basis, EBITDA fell 71.93% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $9.1 million, a 12.56% increase from a year earlier, with the FY2025 full-year figure at $12.5 million, up 100.35% from the prior year.
• EBITDA fell to $1.3 million in Q1 2026 per NCSM's latest filing, from $5.7 million in the prior quarter.
• Across five years, EBITDA topped out at $5.7 million in Q4 2025 and bottomed at -$6.7 million in Q2 2023.
• The 5-year median for EBITDA is $2.2 million (2022), against an average of $876647.1.
• Across the five-year window, EBITDA plunged 149.48% in 2023 and soared 410.96% in 2024, its largest moves.
• Year by year, EBITDA stood at $2.2 million in 2022, then plunged by 149.48% to -$1.1 million in 2023, then surged by 410.96% to $3.4 million in 2024, then surged by 66.27% to $5.7 million in 2025, then plunged by 76.51% to $1.3 million in 2026.
• Per Business Quant, the three latest NCSM EBITDA figures stand at $1.3 million (Q1 2026), $5.7 million (Q4 2025), and $3.6 million (Q3 2025).